Wells Fargo & Company Evolus, Inc. Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Evolus, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 34,841 shares of EOLS stock, worth $379,418. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,841

Previous 23,480 48.39%

Holding current value

$379,418

Previous $254,000 122.05%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$10.66 - $17.48 $121,108 - $198,590	11,361 Added 48.39%	34,841 $564,000
Q2 2024 Aug 13, 2024	BUY	$10.45 - $13.76 $88,198 - $116,134	8,440 Added 56.12%	23,480 $254,000
Q1 2024 May 10, 2024	BUY	$9.99 - $14.91 $15,664 - $23,378	1,568 Added 11.64%	15,040 $210,000
Q4 2023 Feb 09, 2024	SELL	$7.6 - $10.53 $3,450 - $4,780	-454 Reduced 3.26%	13,472 $141,000
Q3 2023 Nov 13, 2023	SELL	$7.15 - $10.2 $316,980 - $452,196	-44,333 Reduced 76.1%	13,926 $127,000
Q2 2023 Aug 15, 2023	BUY	$7.23 - $10.52 $338,053 - $491,883	46,757 Added 406.51%	58,259 $423,000
Q1 2023 May 12, 2023	BUY	$7.81 - $11.05 $45,758 - $64,741	5,859 Added 103.83%	11,502 $97,000
Q4 2022 Feb 13, 2023	BUY	$6.52 - $8.95 $4,844 - $6,649	743 Added 15.16%	5,643 $42,000
Q3 2022 Nov 14, 2022	SELL	$7.76 - $13.72 $27,408 - $48,459	-3,532 Reduced 41.89%	4,900 $39,000
Q2 2022 Aug 12, 2022	SELL	$10.22 - $13.94 $98,939 - $134,953	-9,681 Reduced 53.45%	8,432 $98,000
Q1 2022 May 16, 2022	SELL	$5.22 - $11.78 $51,077 - $115,267	-9,785 Reduced 35.07%	18,113 $203,000
Q4 2021 Feb 14, 2022	SELL	$5.37 - $8.38 $176,485 - $275,408	-32,865 Reduced 54.09%	27,898 $182,000
Q3 2021 Nov 15, 2021	BUY	$7.36 - $13.67 $299,529 - $556,327	40,697 Added 202.82%	60,763 $462,000
Q2 2021 Aug 16, 2021	BUY	$8.42 - $13.96 $55,142 - $91,424	6,549 Added 48.45%	20,066 $253,000
Q1 2021 May 13, 2021	SELL	$3.2 - $16.51 $135,228 - $697,696	-42,259 Reduced 75.77%	13,517 $176,000
Q4 2020 Feb 09, 2021	BUY	$2.92 - $4.84 $83,374 - $138,196	28,553 Added 104.89%	55,776 $187,000
Q3 2020 Nov 05, 2020	SELL	$3.03 - $5.48 $53,306 - $96,409	-17,593 Reduced 39.26%	27,223 $107,000
Q2 2020 Aug 13, 2020	SELL	$3.53 - $6.17 $40,457 - $70,714	-11,461 Reduced 20.37%	44,816 $237,000
Q1 2020 May 14, 2020	BUY	$3.53 - $12.21 $198,657 - $687,142	56,277 New	56,277 $234,000

Others Institutions Holding EOLS

# of Institutions

168

Shares Held

47.8M

Call Options Held

130K

Put Options Held

51K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $611M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Evolus, Inc. Transaction History